Iovance (IOVA) Hits 52-Week High as Analyst Doubles Price Target [Yahoo! Finance]
Iovance Biotherapeutics, Inc. (IOVA)
Last iovance biotherapeutics, inc. earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
iovance.com
Company Research
Source: Yahoo! Finance
Iovance climbed to a new 52-week high on Friday, extending a three-day run, as investors gobbled up shares after an investment firm doubled its price target for its stock. At intra-day trading, Iovance Biotherapeutics Inc. (NASDAQ:IOVA) climbed to its highest price of $5.34 before paring gains to finish the session just up by 12.01 percent at $5.13 apiece. iovance Photo from Iovance Biotherapeutics website In a market report, UBS raised its price target for the biopharmaceutical company to $4 from $2 previously, albeit remaining “neutral” for the stock. On the other hand, Iovance Biotherapeutics Inc. (NASDAQ:IOVA) maintained a more bullish rating from Wells Fargo, with the investment firm reaffirming its $14 price target and “buy” recommendation. On Wednesday, March 11, investors will be closely watching out for business updates from Iovance Biotherapeutics Inc. (NASDAQ:IOVA) amid its participation in Barclays' 28th Annual Global Healthcare Conference. In recent news, t
Show less
Read more
Impact Snapshot
Event Time:
IOVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IOVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IOVA alerts
High impacting Iovance Biotherapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
IOVA
News
- Iovance Biotherapeutics (IOVA) Announces Positive Early Data for Lifileucel TIL Therapy in Advanced Sarcomas [Yahoo! Finance]Yahoo! Finance
- Iovance Sarcoma Trial Data Puts TIL Platform And Stock In Focus [Yahoo! Finance]Yahoo! Finance
- Iovance (IOVA) Soars 33%, Hits All-Time High [Yahoo! Finance]Yahoo! Finance
- UBS Raises PT on Iovance Biotherapeutics (IOVA) [Yahoo! Finance]Yahoo! Finance
- Iovance Biotherapeutics: The High-Risk Cancer Stock I Think Could Change a Portfolio by 2036 [Yahoo! Finance]Yahoo! Finance
IOVA
Earnings
- 2/24/26 - Beat
IOVA
Sec Filings
- 3/11/26 - Form 4
- 3/11/26 - Form 4
- 3/11/26 - Form 4
- IOVA's page on the SEC website